Chromatographic Workflows for Biopharmaceutical Characterization

Significance of the Topic

Monoclonal antibodies and other biotherapeutics are complex molecules with structural heterogeneity affecting efficacy, safety, and regulatory compliance. Robust chromatographic workflows enable comprehensive profiling of attributes such as glycan microheterogeneity, charge variants, aggregates, and sequence integrity.

Study Aims and Overview

This application note by Thermo Fisher Scientific outlines an integrated set of chromatographic methods and instrumentation for biopharmaceutical characterization. Key objectives include standardizing workflows for titer determination, aggregate screening, charge variant analysis, subunit and intact mass measurement, peptide mapping, and native mass spectrometry.

Methodology and Instrumentation

• Size-exclusion chromatography (SEC) on MAbPac SEC-1 and Acclaim SEC-300 columns for aggregate and fragment analysis, UV and light scattering detection.
• Cation exchange chromatography (CEX) on MAbPac SCX-10 and ProPac WCX-10 columns, using salt or pH gradient elution for charge variant profiling, UV detection.
• Hydrophobic interaction chromatography (HIC) on MAbPac HIC-10/20 for oxidation and ADC analysis, UV detection.
• Reverse-phase chromatography (RP) on MAbPac RP and Acclaim C18 columns for intact mass and peptide mapping, coupled to Q Exactive series Orbitrap mass spectrometers with the BioPharma Option.
• Automation and fast digestion using Thermo Scientific SMART Digest kits, FabRICATOR (IdeS) enzyme, and Vanquish UHPLC system.
• Software tools: Thermo Scientific BioPharma Finder for sequence and peptide identification.

Main Results and Discussion

• SEC formats: Three column diameters (7.8 × 300 mm, 4.0 × 300 mm, 2.1 × 150–300 mm) balance resolution, throughput, and MS compatibility. Smaller IDs reduce sample dispersion and maintain peak shape even with larger injection volumes; lifetime tests exceed 1,950 injections with stable performance.
• Peptide mapping reproducibility: Overlay of 13 consecutive runs on Acclaim RSLC 120 C18 column shows retention time RSD < 0.1 %. Sequence coverage of mAbs exceeds 100 % in under 90 minutes using SMART Digest kits and Vanquish UHPLC coupled to Q Exactive.
• Charge variant analysis: pH gradient elution on SCX columns offers universal applicability, rapid method development, high throughput, and compatibility with native MS. Sub-minute gradients maintain resolution of acidic and basic variants. MS-friendly eluents enable direct CEX–MS coupling, preserving peak resolution and facilitating online mass confirmation.
• Native mass spectrometry: Vanquish UHPLC coupled to Q Exactive orbitrap under native conditions resolves intact glycoforms and charge variants. Native MS improves spectral resolution by preserving quaternary structure and reducing charge distribution complexity.

Benefits and Practical Applications

• Unified platform: Single Vanquish UHPLC setup with interchangeable columns supports multiple workflows, reducing instrument footprint and simplifying method transfer between R&D and QC.
• Automation: SMART Digest kits and walk-up UHPLC reduce hands-on time, minimize manual steps, and improve reproducibility across users and labs.
• Time savings: Complete peptide mapping in < 90 minutes and fast pH gradient CVA in under 1 minute accelerate decision-making during candidate screening.
• Comprehensive characterization: Integration of UV, MS, and light scattering detectors provides orthogonal data on mass, charge, and aggregation in a single workflow.

Future Trends and Potential Applications

Continuous advancements in column chemistry and UHPLC hardware will enable even shorter gradients and higher throughput. Emerging mass spectrometry options promise deeper proteoform resolution, real-time process monitoring, and automation via AI-assisted data analysis. Integration of native separation techniques with high-resolution MS and advanced software will expand applications to biosimilar comparability, real-time release testing, and personalized medicine.

Conclusion

The presented chromatographic workflows leverage Thermo Fisher Scientific’s Biopharma portfolio to deliver robust, reproducible, and high-throughput methods for biopharmaceutical characterization. Automation, rapid method development, and direct MS coupling facilitate comprehensive profiling of critical quality attributes across research and manufacturing pipelines.

References

No references were provided in the original text.